Skip to main content
Premium Trial:

Request an Annual Quote

Medicover, FYR Diagnostics Strike Dx Services Partnership

NEW YORK — Swedish diagnostics firm Medicover has partnered with FYR Diagnostics to offer diagnostic development and testing services to pharmaceutical companies in North America, the companies said on Wednesday.

Under the terms of the deal, the companies will use Missoula, Montana-based FYR's CLIA lab to provide pharma partners support for clinical trial assay development and implementation and novel diagnostic technology development, as well as companion diagnostic testing services. Additional terms were not disclosed.

"This collaboration represents a milestone for our precision medicine activities in the United States and expands our global reach and offerings to pharmaceutical partners," Rainer Metzger, Medicover's head of integrated clinical services, said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.